Merit Medical (NASDAQ: MMSI) director granted 3,457 RSUs and holds options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MERIT MEDICAL SYSTEMS INC director Thomas J. Gunderson reported an equity award and his current holdings. He received a grant of 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. These RSUs vest on May 3, 2027, subject to his continued service with the company through that date.
Following the award, Gunderson directly holds 39,491 shares of Common Stock. He also holds non-qualified stock options to acquire 7,500 and 13,750 shares of Common Stock at an exercise price of $52.17 per share, expiring on May 31, 2026 and May 24, 2026, respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Gunderson Thomas J.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, No Par Value | 3,457 | $0.00 | -- |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
Holdings After Transaction:
Common Stock, No Par Value — 39,491 shares (Direct, null);
Non-qualified stock options (right to buy) — 13,750 shares (Direct, null)
Footnotes (1)
- The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.
Key Figures
RSUs granted: 3,457 units
Shares held after grant: 39,491 shares
Option grant 1 underlying shares: 7,500 shares
+3 more
6 metrics
RSUs granted
3,457 units
Restricted stock units granted under 2026 Equity Incentive Plan
Shares held after grant
39,491 shares
Common Stock directly held following reported transactions
Option grant 1 underlying shares
7,500 shares
Non-qualified stock options, exercise price $52.17, expire May 31, 2026
Option grant 2 underlying shares
13,750 shares
Non-qualified stock options, exercise price $52.17, expire May 24, 2026
Option exercise price
$52.17 per share
Exercise price for both non-qualified stock option positions
RSU vesting date
May 3, 2027
Vesting date for 3,457 restricted stock units, subject to continued service
Key Terms
restricted stock units (RSUs), Non-qualified stock options, Equity Incentive Plan, exercise price, +1 more
5 terms
restricted stock units (RSUs) financial
"The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Non-qualified stock options financial
"Non-qualified stock options (right to buy)"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
exercise price financial
"exercisePrice": "52.1700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expirationDate": "2026-05-31T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did MMSI director Thomas J. Gunderson report?
Thomas J. Gunderson reported receiving 3,457 restricted stock units in Merit Medical Systems, Inc. stock. The units were granted under the company’s 2026 Equity Incentive Plan and represent a compensation-related equity award rather than an open-market stock purchase or sale.
When do Thomas J. Gunderson’s new MMSI RSUs vest?
The 3,457 restricted stock units granted to Thomas J. Gunderson vest on May 3, 2027. Vesting is conditioned on his continued service to Merit Medical Systems, Inc. through that vesting date, meaning he must remain in his role to receive the underlying shares.
What stock options does Thomas J. Gunderson hold in MMSI?
Thomas J. Gunderson holds non-qualified stock options linked to 7,500 and 13,750 Merit Medical Systems, Inc. common shares. Both option grants carry a $52.17 exercise price per share and expire on May 31, 2026 and May 24, 2026, respectively, if not exercised.
Is the MMSI Form 4 transaction an open-market buy or sell?
The Form 4 for Merit Medical Systems, Inc. shows a grant coded as an acquisition (A), not an open-market trade. Gunderson received 3,457 restricted stock units as a compensation award, with no reported open-market buying or selling activity in this filing.